Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity

The purpose of this study was to explore the relationships between heart rate variability (HRV) and various phenotypic measures that relate to health and functional status in chronic obstructive pulmonary disease (COPD), and secondly, to demonstrate the feasibility of ascertaining HRV via a chest-wo...

Full description

Bibliographic Details
Main Authors: Seon-Cheol Park, Narongkorn Saiphoklang, Donghyun Jung, David Gomez, Jonathan E. Phillips, Brett A. Dolezal, Donald P. Tashkin, Igor Barjaktarevic, Christopher B. Cooper
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/22/6/2264
_version_ 1797442365640671232
author Seon-Cheol Park
Narongkorn Saiphoklang
Donghyun Jung
David Gomez
Jonathan E. Phillips
Brett A. Dolezal
Donald P. Tashkin
Igor Barjaktarevic
Christopher B. Cooper
author_facet Seon-Cheol Park
Narongkorn Saiphoklang
Donghyun Jung
David Gomez
Jonathan E. Phillips
Brett A. Dolezal
Donald P. Tashkin
Igor Barjaktarevic
Christopher B. Cooper
author_sort Seon-Cheol Park
collection DOAJ
description The purpose of this study was to explore the relationships between heart rate variability (HRV) and various phenotypic measures that relate to health and functional status in chronic obstructive pulmonary disease (COPD), and secondly, to demonstrate the feasibility of ascertaining HRV via a chest-worn wearable biosensor in COPD patients. HRV analysis was performed using SDNN (standard deviation of the mean of all normal R-R intervals), low frequency (LF), high frequency (HF), and LF/HF ratio. We evaluated the associations between HRV and COPD severity, class of bronchodilator therapy prescribed, and patient reported outcomes. Seventy-nine participants with COPD were enrolled. There were no differences in SDNN, HF, and LF/HF ratio according to COPD severity. The SDNN in participants treated with concurrent beta-agonists and muscarinic antagonists was lower than that in other participants after adjusting heart rate (beta coefficient −3.980, <i>p</i> = 0.019). The SDNN was positively correlated with Veterans Specific Activity Questionnaire (VSAQ) score (<i>r</i> = 0.308, <i>p</i> = 0.006) and handgrip strength (<i>r</i> = 0.285, <i>p</i> = 0.011), and negatively correlated with dyspnea by modified Medical Research Council (mMRC) questionnaire (<i>r</i> = −0.234, <i>p</i> = 0.039), health status by Saint George’s Respiratory Questionnaire (SGRQ) (<i>r</i> = −0.298, <i>p</i> = 0.008), symptoms by COPD Assessment Test (CAT) (<i>r</i> = −0.280, <i>p</i> = 0.012), and BODE index (<i>r</i> = −0.269, <i>p</i> = 0.020). When measured by a chest-worn wearable device, reduced HRV was observed in COPD participants receiving inhaled beta-sympathomimetic agonist and muscarinic antagonists. HRV was also correlated with various health status and performance measures.
first_indexed 2024-03-09T12:40:50Z
format Article
id doaj.art-624e0d8c6c80473cbe9f0acf0d40cc4a
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-09T12:40:50Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-624e0d8c6c80473cbe9f0acf0d40cc4a2023-11-30T22:18:30ZengMDPI AGSensors1424-82202022-03-01226226410.3390/s22062264Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease SeveritySeon-Cheol Park0Narongkorn Saiphoklang1Donghyun Jung2David Gomez3Jonathan E. Phillips4Brett A. Dolezal5Donald P. Tashkin6Igor Barjaktarevic7Christopher B. Cooper8Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAUCLA Airways and Exercise Physiology Research Laboratory, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAUCLA Airways and Exercise Physiology Research Laboratory, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAInflammation Discovery Research, Amgen, Thousand Oaks, CA 91320, USADivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USADivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USAThe purpose of this study was to explore the relationships between heart rate variability (HRV) and various phenotypic measures that relate to health and functional status in chronic obstructive pulmonary disease (COPD), and secondly, to demonstrate the feasibility of ascertaining HRV via a chest-worn wearable biosensor in COPD patients. HRV analysis was performed using SDNN (standard deviation of the mean of all normal R-R intervals), low frequency (LF), high frequency (HF), and LF/HF ratio. We evaluated the associations between HRV and COPD severity, class of bronchodilator therapy prescribed, and patient reported outcomes. Seventy-nine participants with COPD were enrolled. There were no differences in SDNN, HF, and LF/HF ratio according to COPD severity. The SDNN in participants treated with concurrent beta-agonists and muscarinic antagonists was lower than that in other participants after adjusting heart rate (beta coefficient −3.980, <i>p</i> = 0.019). The SDNN was positively correlated with Veterans Specific Activity Questionnaire (VSAQ) score (<i>r</i> = 0.308, <i>p</i> = 0.006) and handgrip strength (<i>r</i> = 0.285, <i>p</i> = 0.011), and negatively correlated with dyspnea by modified Medical Research Council (mMRC) questionnaire (<i>r</i> = −0.234, <i>p</i> = 0.039), health status by Saint George’s Respiratory Questionnaire (SGRQ) (<i>r</i> = −0.298, <i>p</i> = 0.008), symptoms by COPD Assessment Test (CAT) (<i>r</i> = −0.280, <i>p</i> = 0.012), and BODE index (<i>r</i> = −0.269, <i>p</i> = 0.020). When measured by a chest-worn wearable device, reduced HRV was observed in COPD participants receiving inhaled beta-sympathomimetic agonist and muscarinic antagonists. HRV was also correlated with various health status and performance measures.https://www.mdpi.com/1424-8220/22/6/2264heart rate variabilitywearable sensorschronic obstructive pulmonary diseasebronchodilatorhealth
spellingShingle Seon-Cheol Park
Narongkorn Saiphoklang
Donghyun Jung
David Gomez
Jonathan E. Phillips
Brett A. Dolezal
Donald P. Tashkin
Igor Barjaktarevic
Christopher B. Cooper
Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
Sensors
heart rate variability
wearable sensors
chronic obstructive pulmonary disease
bronchodilator
health
title Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
title_full Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
title_fullStr Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
title_full_unstemmed Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
title_short Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity
title_sort use of a wearable biosensor to study heart rate variability in chronic obstructive pulmonary disease and its relationship to disease severity
topic heart rate variability
wearable sensors
chronic obstructive pulmonary disease
bronchodilator
health
url https://www.mdpi.com/1424-8220/22/6/2264
work_keys_str_mv AT seoncheolpark useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT narongkornsaiphoklang useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT donghyunjung useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT davidgomez useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT jonathanephillips useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT brettadolezal useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT donaldptashkin useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT igorbarjaktarevic useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity
AT christopherbcooper useofawearablebiosensortostudyheartratevariabilityinchronicobstructivepulmonarydiseaseanditsrelationshiptodiseaseseverity